RadioGraphics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online November 19, 2008, 10.1148/rg.291085072

(RadioGraphics 2009;29:9.)

A more recent version of this article appeared on January 1, 2009
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow All Versions of this Article:
291085072v1
29/1/9    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juluru, K.
Right arrow Articles by Bluemke, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juluru, K.
Right arrow Articles by Bluemke, D. A.
© RSNA, 2008

Quality Initiatives

MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety1

Krishna Juluru, MD, Jens Vogel-Claussen, MD, Katarzyna J. Macura, MD, PhD, Ihab R. Kamel, MD, PhD, Alexander Steever, MD, and David A. Bluemke, MD, PhD

1 From the Department of Radiology, Weill Cornell Medical Center, 525 E 68th St, F-056, New York, NY 10065 (K.J., A.S.); and Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Md (J.V.C., K.J.M., I.R.K., D.A.B.). Presented as an education exhibit at the 2007 RSNA Annual Meeting. Received March 27, 2008; revision requested June 3 and received July 18; accepted July 23. J.V.C. received a research grant from Siemens; D.A.B. is a consultant with GE Healthcare; I.R.K. received a research grant from Bracco; all remaining authors have no financial relationships to disclose. Address correspondence to K.J. (e-mail: kjuluru{at}med.cornell.edu).

Abstract

Nephrogenic systemic fibrosis (NSF) is a rare but potentially debilitating or even fatal fibrosing condition that most often affects the skin but is now also recognized to involve multiple organs. The first report on NSF was published in 1997, and there is mounting evidence that this condition is associated with renal failure and the administration of large amounts of gadolinium. Although gadolinium-enhanced magnetic resonance (MR) imaging was once considered one of the safer imaging procedures, concerns over NSF have led the radiology community to rethink its imaging practices. Several noncontrast angiographic techniques based on fast spin-echo, gradient-echo, phase-contrast, and inversion-recovery principles are currently available. These techniques allow MR angiography to be performed safely, even in patients at risk for developing NSF. When use of gadolinium-based contrast material is necessary for diagnosis, it is possible to reduce total gadolinium administration through the use of agents with higher relaxivity, time-resolved imaging, high-field-strength magnets, and body compression devices. Management of NSF also requires an understanding of the risk factors of this disease and developing an institutional policy for identifying and testing at-risk patients.

© RSNA, 2009







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOGRAPHICS RADIOLOGY RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.